Name | Cvs Pharmacy #09290 |
---|---|
Organization Name | Arizona Cvs Stores Llc |
Location | 4430 E Ray Rd, Phoenix, Arizona 85044 |
Type | Pharmacy |
Phone | (480) 785-1006 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
While the study does not look at the effectiveness of these treatments, "what's concerning is that young people across the country have different levels of access to alternative therapies as publicly-funded services," says Dr. McColl. "There are noticeable differences in access and utilization based on education, income and geographic location."
A study led by the Barcelona Institute for Global Health (ISGlobal) - an institution supported by "la Caixa" Foundation- reveals a new mechanism by which the malaria parasite Plasmodium falciparum converts from its asexual to its sexual form, which can be transmitted to the mosquito.
ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company's CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.
A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors.
› Verified 9 days ago
NPI Number | 1851332761 |
Organization Name | ARIZONA CVS STORES LLC |
Doing Business As | CVS PHARMACY 09290 |
Type | Pharmacy |
Address | 4430 E Ray Rd, Phoenix, AZ 85044 |
Phone Number | 480-785-1006 |
News Archive
While the study does not look at the effectiveness of these treatments, "what's concerning is that young people across the country have different levels of access to alternative therapies as publicly-funded services," says Dr. McColl. "There are noticeable differences in access and utilization based on education, income and geographic location."
A study led by the Barcelona Institute for Global Health (ISGlobal) - an institution supported by "la Caixa" Foundation- reveals a new mechanism by which the malaria parasite Plasmodium falciparum converts from its asexual to its sexual form, which can be transmitted to the mosquito.
ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company's CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.
A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors.
› Verified 9 days ago
News Archive
While the study does not look at the effectiveness of these treatments, "what's concerning is that young people across the country have different levels of access to alternative therapies as publicly-funded services," says Dr. McColl. "There are noticeable differences in access and utilization based on education, income and geographic location."
A study led by the Barcelona Institute for Global Health (ISGlobal) - an institution supported by "la Caixa" Foundation- reveals a new mechanism by which the malaria parasite Plasmodium falciparum converts from its asexual to its sexual form, which can be transmitted to the mosquito.
ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company's CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.
A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors.
› Verified 9 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |